Patient adherence to hereditary cancer risk management: a 10-year experience in Singapore

As the Cancer Genetics Service (CGS) in Singapore marks its tenth year, we evaluated adherence to recommended risk management among patients with hereditary cancer syndromes (HCS) to inform service improvements and cost-effectiveness analyses. We conducted a retrospective review of surveillance behaviours, uptake of risk-reducing surgery, and cancers detected during follow-up. Statistical tests were conducted to assess association between patient characteristics and adherence behaviours. There were 729 patients with HCS, largely comprised of females (79.7%), Chinese (73.5%), with a syndrome-related manifestation prior to testing (74.1%) and a family history of cancer (90.9%). Overall, 66.4% of our patients were fully adherent (FA) to recommended risk management; 10.4% were highly adherent (HA), 14.4% were lowly adherent (LA) and 8.8% were non-adherent (NA). Overall adherence was high across most HCS cohorts. Higher adherence was observed among individuals with high risk HCS, including Hereditary Breast Ovarian Cancer Syndrome, Lynch Syndrome and Familial Adenomatous Polyposis. High adherence of Neurofibromatosis Type 1 patients suggests that access to coordinated, multidisciplinary services may facilitate adherence. As healthcare systems move toward precision public health, strengthening risk communication and investing in multidisciplinary care models should be prioritised to support adherence to recommended risk-management strategies, particularly in high-risk populations.

Authors

Institutions

Publication Details

Journal
npj Genomic Medicine
Published
2026-11-21
DOI
https://doi.org/10.1038/s41525-026-00633-5
Primary Topic
BRCA gene mutations in cancer
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Patient adherence to hereditary cancer risk management: a 10-year experience in Singapore

Zewen Zhang, Sowmya Jonnagadla, Diana Ishak, Shun Zi Liong et al.
2 links
npj Genomic Medicine
BRCA gene mutations in cancer
article

Patient adherence to hereditary cancer risk management: a 10-year experience in Singapore

Zewen Zhang, Sowmya Jonnagadla, Diana Ishak, Shun Zi Liong, CHIANG JIANBANG, Joanne Ngeow, Shao-Tzu Li, Jeanette Yuen
article en

Abstract

As the Cancer Genetics Service (CGS) in Singapore marks its tenth year, we evaluated adherence to recommended risk management among patients with hereditary cancer syndromes (HCS) to inform service improvements and cost-effectiveness analyses. We conducted a retrospective review of surveillance behaviours, uptake of risk-reducing surgery, and cancers detected during follow-up. Statistical tests were conducted to assess association between patient characteristics and adherence behaviours. There were 729 patients with HCS, largely comprised of females (79.7%), Chinese (73.5%), with a syndrome-related manifestation prior to testing (74.1%) and a family history of cancer (90.9%). Overall, 66.4% of our patients were fully adherent (FA) to recommended risk management; 10.4% were highly adherent (HA), 14.4% were lowly adherent (LA) and 8.8% were non-adherent (NA). Overall adherence was high across most HCS cohorts. Higher adherence was observed among individuals with high risk HCS, including Hereditary Breast Ovarian Cancer Syndrome, Lynch Syndrome and Familial Adenomatous Polyposis. High adherence of Neurofibromatosis Type 1 patients suggests that access to coordinated, multidisciplinary services may facilitate adherence. As healthcare systems move toward precision public health, strengthening risk communication and investing in multidisciplinary care models should be prioritised to support adherence to recommended risk-management strategies, particularly in high-risk populations.

npj Genomic Medicine
Nanyang Technological University (SG), National Cancer Centre Singapore (SG)
National Cancer Centre of Singapore, Singapore Cancer Society, National Research Foundation, Precision Health Research, Singapore, National Medical Research Council
Good health and well-being
BRCA gene mutations in cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon